Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFP versus Omniplasma coagulation study in pediatric congenital heart surgery
NL-OMON51227Recruiting
- Sponsor
- Anesthesiologie
- Start
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of octaplas lg and fresh-frozen plasma in Cardiovascular Malformation (CVM) (2 arms), sponsored by Anesthesiologie. Primary endpoint: Difference in coagulation variables between FFP and Omniplasma. Started Jul 2021; status: recruiting.
02
Drugs
octaplas lgfresh-frozen plasma
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on NL-OMON51227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51227.